Abstract
The Arizona bark scorpion, Centruroides sculpturatus, is the only scorpion endemic to the United States that produces a systemic envenomation in humans. Most stings do not result in serious symptoms however, and children are much more likely than adults to experience life-threatening effects. Serious envenomations are classified as Grade III and Grade IV. Findings include neuromuscular hyperactivity, with myoclonic muscle movements, fasciculations, thrashing and twisting of the torso, and restless agitation. Cranial nerve findings also occur and include opsoclonus, with dysconjugate and roving eye movements, as well as tongue fasciculations, hypersalivation, incoordination of pharyngeal muscles, and stridor. Local tissue findings at the sting site do not occur. Severe bark scorpion envenomation may be managed with supportive care and airway interventions as needed. Deaths occur from respiratory failure and hypoxia. An anti-Centruroides antivenom is available for treatment of serious bark scorpion stings. The antivenom reverses clinical toxicity within about an hour of administration. With or without antivenom treatment, most patients have full recovery from the envenomation in about 24 h.
References
Aksel G, Guler S, Dogan NO, Corbacioglu SK. A randomized trial comparing intravenous paracetamol, topical lidocaine, and ice application for treatment of pain associated with scorpion stings. Hum Exp Toxicol. 2015;34(6):662–7.
Boyer LV, Theodorou AA, Berg RA, Mallie J, Chavez-Mendez A, Garcia-Ubbelohde W, et al. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. 2009;360(20):2090–8.
Boyer L, Degan J, Ruha AM, Mallie J, Mangin E, Alagon A. Safety of intravenous equine F(ab’)2: insights following clinical trials involving 1534 recipients of scorpion antivenom. Toxicon. 2013;76:386–93.
Calderon-Aranda ES, Riviere G, Choumet V, Possani LD, Bon C. Pharmacokinetics of the toxic fraction of Centruroides limpidus limpidus venom in experimentally envenomed rabbits and effects of immunotherapy with specific F(ab’)2. Toxicon. 1999;37(5):771–82.
Campos FV, Chanda B, Beirao PS, Bezanilla F. Beta-scorpion toxin modifies gating transitions in all four voltage sensors of the sodium channel. J Gen Physiol. 2007;130(3):257–68.
Campos FV, Chanda B, Beirao PS, Bezanilla F. Alpha-scorpion toxin impairs a conformational change that leads to fast inactivation of muscle sodium channels. J Gen Physiol. 2008;132(2):251–63.
Chase P, Boyer-Hassen L, McNally J, Vazquez HL, Theodorou AA, Walter FG, et al. Serum levels and urine detection of Centruroides sculpturatus venom in significantly envenomated patients. Clin Toxicol (Phila). 2009;47(1):24–8.
Coorg V, Levitan RD, Gerkin RD, Muenzer J, Ruha AM. Clinical presentation and outcomes associated with different treatment modalities for pediatric bark scorpion envenomation. J Med Toxicol. 2017;13(1):66–70.
Corzo G, Espino-Solis GP. Selected scorpion toxin exposures induce cytokine release in human peripheral blood mononuclear cells. Toxicon. 2017;127:56–62.
Curry SC, Vance MV, Ryan PJ, Kunkel DB, Northey WT. Envenomation by the scorpion Centruroides sculpturatus. J Toxicol Clin Toxicol. 1983;21(4–5):417–49.
Devaux C, Jouirou B, Naceur Krifi M, Clot-Faybesse O, El Ayeb M, Rochat H. Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom. Toxicon. 2004;43(6):661–9.
Gibly R, Williams M, Walter FG, McNally J, Conroy C, Berg RA. Continuous intravenous midazolam infusion for Centruroides exilicauda scorpion envenomation. Ann Emerg Med. 1999;34(5):620–5.
Hiller K, Jarrod MM, Franke HA, Degan J, Boyer LV, Fox FM. Scorpion antivenom administered by alternative infusions. Ann Emerg Med. 2010;56(3):309–10.
Isbister GK, Bawaskar HS. Scorpion envenomation. N Engl J Med. 2014;371(5):457–63.
Kang AM, Brooks DE. Nationwide scorpion exposures reported to US poison control centers from 2005 to 2015. J Med Toxicol. 2017;13(2):158–65.
Kolecki P. Inadvertent methamphetamine poisoning in pediatric patients. Pediatr Emerg Care. 1998;14(6):385–7.
Krifi MN, Savin S, Debray M, Bon C, El Ayeb M, Choumet V. Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy. Toxicon. 2005;45(2):187–98.
Lutkin S. Arizona hospital’s $80,000 bill stings worse than scorpion venom: ABC news. 2012. Available from: http://abcnews.go.com/Health/arizona-hospitals-80000-bill-stings-worse-scorpion-venom/story?id=17163685. 30 Apr 2017.
More D, Nugent J, Hagan L, Demain J, Schwertner H, Whisman B, et al. Identification of allergens in the venom of the common striped scorpion. Ann Allergy Asthma Immunol. 2004;93(5):493–8.
Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol (Phila). 2014;52(10):1032–283.
O’Connor A, Ruha AM. Clinical course of bark scorpion envenomation managed without antivenom. J Med Toxicol. 2012;8(3):258–62.
Osnaya-Romero N, Acosta-Saavedra LC, Goytia-Acevedo R, Lares-Asseff I, Basurto-Celaya G, Perez-Guille G, et al. Serum level of scorpion toxins, electrolytes and electrocardiogram alterations in Mexican children envenomed by scorpion sting. Toxicon. 2016;122:103–8.
Quintero-Hernandez V, Jimenez-Vargas JM, Gurrola GB, Valdivia HH, Possani LD. Scorpion venom components that affect ion-channels function. Toxicon. 2013;76:328–42.
Rendon-Anaya M, Delaye L, Possani LD, Herrera-Estrella A. Global transcriptome analysis of the scorpion Centruroides noxius: new toxin families and evolutionary insights from an ancestral scorpion species. PLoS One. 2012;7(8):e43331.
Santibanez-Lopez CE, Francke OF, Ureta C, Possani LD. Scorpions from Mexico: from species diversity to venom complexity. Toxins. 2015;8(1).
Stahnke HL. The venomous effects of some Arizona scorpions. Science. 1938;88(2277):166–7.
Stahnke H. The Arizona scorpion problem. Ariz Med. 1950;7(3):23–9.
Strommen J, Shirazi F. Methamphetamine ingestion misdiagnosed as Centruroides sculpturatus envenomation. Case Rep Emer Med. 2015;2015:320574.
Suchard JR, Hilder R. Atropine use in Centruroides scorpion envenomation. J Toxicol Clin Toxicol. 2001;39(6):595–8; discussion 9.
Therapeutics RD. Centruroides (scorpion) immune F(ab’)2 (equine) injection. 2011. Available from: https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-bio-gen/documents/document/ucm266725.pdf
Vazquez H, Chavez-Haro A, Garcia-Ubbelohde W, Paniagua-Solis J, Alagon A, Sevcik C. Pharmacokinetics of a F(ab')2 scorpion antivenom administered intramuscularly in healthy human volunteers. Int Immunopharmacol. 2010;10(11):1318–24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media B.V.
About this entry
Cite this entry
Ruha, AM. (2018). North American Scorpion Envenomations. In: Gopalakrishnakone, P., et al. Clinical Toxinology. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6288-6_73-2
Download citation
DOI: https://doi.org/10.1007/978-94-007-6288-6_73-2
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6288-6
Online ISBN: 978-94-007-6288-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
North American Scorpion Envenomations- Published:
- 22 November 2017
DOI: https://doi.org/10.1007/978-94-007-6288-6_73-2
-
Original
Toxinology: North American Scorpion Envenomations- Published:
- 20 September 2017
DOI: https://doi.org/10.1007/978-94-007-6288-6_73-1